| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $0.00176 (Miss by $-0.23824) |
| EPS GAAP Actual | $0.00176 (Miss by $-0.23824) |
| Revenue Actual | $0.390633B |
| Revenue Surprise | Beat by $390.633M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.29 |
| EPS GAAP Estimate | $0.29 |
| Revenue Estimate | $0.225033333B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 1.65 | 7.93 | 1.61924 | 1.6915 | 1 |
| Dec 2026 | 1.3 | 10.07 | 1.25072 | 1.39115 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.0018 | -0.2682 | 0.390633B | 52.76% | 185.43M |
| FQ1 2025 (Mar 2025) | -0.24 | -0.47333 | 0.354588B | 52.22% | 165.22M |
| FQ4 2024 (Dec 2024) | -616.6 | -616.6 | 307.124B | 99.93% | 307124M |
| FQ3 2024 (Sep 2024) | -0.0615 | -0.0615 | 0.199119B | -0.63% | 199.12M |
| FQ2 2024 (Jun 2024) | 0.0129 | 0.0129 | 0.184546B | -0.42% | 184.55M |
| FQ1 2024 (Mar 2024) | -0.0203 | -0.0203 | 0.169416B | -3.6% | 169.42M |
| FQ1 2020 (Mar 2020) | -0.43 | -0.43 | 0.110839B | 100% | 110.84M |
| FQ4 2020 (Dec 2020) | 0.24 | 0.24 | 0.156544B | 100% | 156.54M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.29
Consensus Revenue Estimates
0.225033333B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.47 | -- | 0.46203 | 0.47822 | 3 |
| FQ3 2027 (Sep 2027) | 0.4494 | -- | 0.44178 | 0.45726 | 3 |
| FQ2 2027 (Jun 2027) | 0.4192 | -- | 0.41209 | 0.42653 | 3 |
| FQ1 2027 (Mar 2027) | 0.3081 | -- | 0.30288 | 0.31349 | 3 |
| FQ4 2026 (Dec 2026) | 0.34 | -- | 0.33642 | 0.3443 | 3 |
| FQ3 2026 (Sep 2026) | 0.31 | -- | 0.30674 | 0.31392 | 3 |
| FQ2 2026 (Jun 2026) | 0.29 | 99.38 | 0.28695 | 0.29366 | 3 |
| FQ1 2026 (Mar 2026) | 0.25 | 196 | 0.24737 | 0.25316 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.3B | -- | 0.3B | 0.3B | 2 |
| FQ3 2027 (Sep 2027) | 0.29B | -- | 0.29B | 0.29B | 2 |
| FQ2 2027 (Jun 2027) | 0.28B | -- | 0.28B | 0.29B | 2 |
| FQ1 2027 (Mar 2027) | 0.27B | -- | 0.27B | 0.28B | 2 |
| FQ4 2026 (Dec 2026) | 0.25B | -- | 0.25B | 0.26B | 4 |
| FQ3 2026 (Sep 2026) | 0.24B | -- | 0.24B | 0.24B | 4 |
| FQ2 2026 (Jun 2026) | 0.21B | -82.37 | 0.21B | 0.22B | 4 |
| FQ1 2026 (Mar 2026) | 0.2B | -80.27 | 0.2B | 0.2B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.27 | 0.0018 | -0.2682 | -14900% |
| FQ1 2025 (Mar 2025) | 0.23333 | -0.24 | -0.47333 | 197.22% |
| FQ4 2024 (Dec 2024) | -616.6 | -616.6 | 100% | |
| FQ3 2024 (Sep 2024) | -0.0615 | -0.0615 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0129 | 0.0129 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0203 | -0.0203 | 100% | |
| FQ1 2020 (Mar 2020) | -0.43 | -0.43 | 100% | |
| FQ4 2020 (Dec 2020) | 0.24 | 0.24 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.21B | $0.39B | $185.43M | 47.47% |
| FQ1 2025 (Mar 2025) | $0.19B | $0.35B | $165.22M | 46.6% |
| FQ4 2024 (Dec 2024) | $0B | $307.12B | $307124M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.2B | $199.12M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.18B | $184.55M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.17B | $169.42M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.11B | $110.84M | 100% |
| FQ4 2020 (Dec 2020) | $0B | $0.16B | $156.54M | 100% |